Catheter Precision - דינמיקת הכנסות משנה לשנה ב-12 החודשים האחרונים VTAK

A stable staff of development engineers ensures the technical resilience of Catheter Precision (VTAK). Year-over-year sales growth (TTM) demonstrates the asset's dynamics, where the indicator is maintained at 218.10. Revenues are based on the supply of non-invasive mapping systems to cardiac centers. The expansion of Amigo robotic systems into the B2B segment aims for a systematic capture of market share in the field of arrhythmia treatment.
Catheter Precision Inc (VTAK) - פילוחי מדדים ודוחות פיננסיים

Catheter Precision high-tech developments in cardiology rely on a unique staff of biomedical experts, which directly converts into market expansion. By analyzing year-over-year sales volatility over a rolling 12-month period, an investor filters out random revenue fluctuations to assess the sustainable pace of business scaling. A stable upward trend confirms the fundamental viability of the model, although a sharp spike in the curve signals a risk of correction should demand subside.